Search research articles
Contact Us
Filters
Showing results (491-500 of 521) with videos related to
Page
of 53
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 1, 2024
Devimistat (CPI-613) With Modified Fluorouarcil, Oxaliplatin, Irinotecan, and Leucovorin (FFX) Versus FFX for Patients With Metastatic Adenocarcinoma of the Pancreas: The Phase III AVENGER 500 Study
Philip A Philip, Vaibhav Sahai, Nathan Bahary, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 28, 2020
Randomized Trial of Irinotecan and Cetuximab With or Without Vemurafenib in BRAF-Mutant Metastatic Colorectal Cancer (SWOG S1406)
Scott Kopetz, Katherine A Guthrie, Van K Morris, et al.
Journal of Surgical Oncology
|
January 11, 2023
Peritoneal metastases from primary appendiceal and colorectal carcinomas demonstrate distinct molecular identities on comprehensive tumor analysis
Andrew M Fleming, Benjamin W Deschner, Forrest W Williard, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 5, 2020
Comprehensive Genomic Profiling of Gastroenteropancreatic Neuroendocrine Neoplasms (GEP-NENs)
Alberto Puccini, Kelsey Poorman, Mohamed E Salem, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 13, 2024
SWOG S1815: A Phase III Randomized Trial of Gemcitabine, Cisplatin, and Nab-Paclitaxel Versus Gemcitabine and Cisplatin in Newly Diagnosed, Advanced Biliary Tract Cancers
Rachna T Shroff, Gentry King, Sarah Colby, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 6, 2025
Trastuzumab Plus Pertuzumab Versus Cetuximab Plus Irinotecan in Patients With <i>RAS/BRAF</i> Wild-Type, HER2-Positive, Metastatic Colorectal Cancer (S1613): A Randomized Phase II Trial
Kanwal Pratap Singh Raghav, Katherine A Guthrie, Benjamin Tan, et al.
ESMO Open
|
June 25, 2020
Molecular profile of BRCA-mutated biliary tract cancers
Gilbert Spizzo, Alberto Puccini, Joanne Xiu, et al.
NPJ Precision Oncology
|
October 28, 2021
Molecular differences between lymph nodes and distant metastases compared with primaries in colorectal cancer patients
Alberto Puccini, Andreas Seeber, Joanne Xiu, et al.
Molecular Cancer Therapeutics
|
September 13, 2023
Anticancer Efficacy of KRASG12C Inhibitors Is Potentiated by PAK4 Inhibitor KPT9274 in Preclinical Models of KRASG12C-Mutant Pancreatic and Lung Cancers
Husain Yar Khan, Misako Nagasaka, Amro Aboukameel, et al.
American Journal of Clinical Oncology
|
January 28, 2020
Results of the NRG Oncology/RTOG 0848 Adjuvant Chemotherapy Question-Erlotinib+Gemcitabine for Resected Cancer of the Pancreatic Head: A Phase II Randomized Clinical Trial
Ross A Abrams, Kathryn A Winter, Howard Safran, et al.
Page
of 53
Search research articles
Search
Showing results (491-500 of 521) with videos related to
Sort By:
Page
of 53
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 1, 2024
Devimistat (CPI-613) With Modified Fluorouarcil, Oxaliplatin, Irinotecan, and Leucovorin (FFX) Versus FFX for Patients With Metastatic Adenocarcinoma of the Pancreas: The Phase III AVENGER 500 Study
Philip A Philip, Vaibhav Sahai, Nathan Bahary, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 28, 2020
Randomized Trial of Irinotecan and Cetuximab With or Without Vemurafenib in BRAF-Mutant Metastatic Colorectal Cancer (SWOG S1406)
Scott Kopetz, Katherine A Guthrie, Van K Morris, et al.
Journal of Surgical Oncology
|
January 11, 2023
Peritoneal metastases from primary appendiceal and colorectal carcinomas demonstrate distinct molecular identities on comprehensive tumor analysis
Andrew M Fleming, Benjamin W Deschner, Forrest W Williard, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 5, 2020
Comprehensive Genomic Profiling of Gastroenteropancreatic Neuroendocrine Neoplasms (GEP-NENs)
Alberto Puccini, Kelsey Poorman, Mohamed E Salem, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 13, 2024
SWOG S1815: A Phase III Randomized Trial of Gemcitabine, Cisplatin, and Nab-Paclitaxel Versus Gemcitabine and Cisplatin in Newly Diagnosed, Advanced Biliary Tract Cancers
Rachna T Shroff, Gentry King, Sarah Colby, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 6, 2025
Trastuzumab Plus Pertuzumab Versus Cetuximab Plus Irinotecan in Patients With <i>RAS/BRAF</i> Wild-Type, HER2-Positive, Metastatic Colorectal Cancer (S1613): A Randomized Phase II Trial
Kanwal Pratap Singh Raghav, Katherine A Guthrie, Benjamin Tan, et al.
ESMO Open
|
June 25, 2020
Molecular profile of BRCA-mutated biliary tract cancers
Gilbert Spizzo, Alberto Puccini, Joanne Xiu, et al.
NPJ Precision Oncology
|
October 28, 2021
Molecular differences between lymph nodes and distant metastases compared with primaries in colorectal cancer patients
Alberto Puccini, Andreas Seeber, Joanne Xiu, et al.
Molecular Cancer Therapeutics
|
September 13, 2023
Anticancer Efficacy of KRASG12C Inhibitors Is Potentiated by PAK4 Inhibitor KPT9274 in Preclinical Models of KRASG12C-Mutant Pancreatic and Lung Cancers
Husain Yar Khan, Misako Nagasaka, Amro Aboukameel, et al.
American Journal of Clinical Oncology
|
January 28, 2020
Results of the NRG Oncology/RTOG 0848 Adjuvant Chemotherapy Question-Erlotinib+Gemcitabine for Resected Cancer of the Pancreatic Head: A Phase II Randomized Clinical Trial
Ross A Abrams, Kathryn A Winter, Howard Safran, et al.
Page
of 53